We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Reverses Ruling for Teva, Amphastar in Lovenox Patent Suit
Court Reverses Ruling for Teva, Amphastar in Lovenox Patent Suit
April 18, 2006
A federal appeals court has reversed a ruling that invalidated a key sanofi-aventis patent on blood thinner Lovenox, giving the company at least a temporary win over generic challengers Teva Pharmaceutical and Amphastar Pharmaceuticals.